Type of stroke suffered, whether ischemic or hemorrhagic, in patients with retinal disease was not influenced by anti-VEGF treatment, according to a study.
A retrospective consecutive review of patient records in the Rochester Epidemiology Project from Jan. 1, 2004, through Dec. 31, 2013, identified 690 patients (case cohort) as receiving an intravitreal injection for age-related macular degeneration (AMD), diabetic macular edema (DME), proliferative diabetic retinopathy (PDR) or retinal vein occlusion (RVO).
The researchers compared the case cohort to two age-and sex-matched cohorts: a prior
Uncategorized